教育经历:
2010-2015,理学博士,化学生物学,北京大学
2006-2010,理学学士,化学,北京大学
工作经历:
2020.9-至今,研究员,北大清华生命科学联合中心
2020.9-至今,研究员,永利官网
2015.11-2020.8,博士后,芝加哥大学化学系
荣誉奖励:
拜耳学者,2022
北京大学博雅青年学者,2022
億方学者,2021
北京市科技新星,2021执教课程:
生物化学与分子生物学研究前沿,本科生
现代生物学基础理论(上),研究生 本实验室致力于研究RNA修饰/non-coding RNA的分子调控机制和相关生物功能。我们运用表观遗传学,分子生物学,结合高通量测序等多种技术手段来探索RNA修饰/ncRNA对于染色质结构和基因转录的新的调控机制,以及相关调控通路在胚胎干细胞分化,抗肿瘤免疫,癌症及衰老中的生物功能。
主要研究方向:
1. 研究RNA表观遗传修饰对于染色质结构和基因转录的分子调控机制及在干细胞命运决定,细胞重编程,抗肿瘤免疫和癌症发展等过程中的相关生物功能;
2. 研究细胞核内ncRNA降解过程的分子调控机制及相关生物功能;
3. 探究RNA表观遗传修饰对于生物大分子相变的相关调控机制及相应的生物功能。
1. Dou, X. Y.*, Huang, L. L.*, Xiao, Y.*, Liu, C., Li, Y. N., Zhang, X. N., Yu, L. S., Zhao, R., Yang, L., Chen, C., Yu, X. B., Gao, B. Y., Qi, M. J., Gao, Y. W., Shen, B., Sun, S. Y., He, C.#, Liu, J.# METTL14 is a chromatin regulator independent of its RNA N6-methyladenosine methyltransferase activity. Protein Cell 2023, just accepted.
2. Liu, J.*, Dou, X. Y.*, Chen, C. Y.*, Chen, C., Liu, C., Xu, M. M., Zhao, S. Q., Shen, B., Gao, Y. W., Han, D. L., He, C. N6-methyladenosine of chromosome-associated regulatory RNA regulates chromatin state and transcription. Science 2020, 367, 580-586.
3. Wang, M.*, Liu, J.*, Zhao, Y.*, He, R.*, Xu, X., Guo, X.; Li, X., Xu, S., Miao, J., Guo, J., Zhang, H., Gong, J., Zhu, F., Tian, R., Shi, C., Peng, F., Feng, Y., Yu, S., Xie, Y., Jiang, J., Li, M.#, Wei, W.#, He, C.#, Qin, R.# Upregulation of METTL14 mediates the elevation of PERP mRNA N6 adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol. Cancer 2020, 19, 130.
4. Hou, J.*; Zhang, H.*; Liu, J.*; Zhao, Z.; Wang, J.; Lu, Z.; Hu, B.; Zhou, J.; Zhao, Z.; Feng, M.; Zhang, H.; Shen, B.; Huang, X.; Sun, B.; Smyth, M.; He, C.; Xia, Q. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol. Cancer 2019, 18, 163-179.
5. Han, D*.; Liu, J*.; Chen, C.; Dong, L.; Huang, X.; Liu, Y.; Wang, J.; Dougherty, U.; Bissonnette, B.; Shen, B.; Weichselbaum, R.; Xu, M.; He, C. Anti-tumor immunity controlled through mRNA m6A and YTHDF1 in dendritic cells. Nature, 2019, 566, 270-274.
6. Liu, J.*; Eckert, M.*; Harada, B.*; Liu, S.*; Lu, Z.; Yu, K.; Tienda, S.; Chryplewicz, A.; Zhu, A.; Yang, Y.; Huang, J.; Chen, S.; Xu, Z.; Leng, X.; Yu, X.; Cao, J.; Zhang, Z.; Liu, J.; Lengyel, E.; He, C. m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer. Nat. Cell Biol. 2018, 20, 1074-1083.
7. Yue, Y.*; Liu, J.*; Cui, X.*; Cao, J.*; Luo, G.; Zhang, Z.; Gao, M.; Shu, X.; Ma, H.; Wang, F.; Shen, B.; Wang, Y.; Feng, X.; He, C.; Liu, J. VIRMA mediates preferential m6A mRNA methylation in 3`UTR and near stop codon and associates with alternative polyadenylation. Cell. Discov. 2018, 4, 10-26.
(*co-authors contributed equally; #Corresponding authors)